Lead sponsor
Georgetown University
5 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
5
Trials led
0
Ongoing
147
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Phase 2
4
Trials by status
Completed
4
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy BodiesDementia with Lewy bodiesPh 2Completed43
K0706 for Patients Diagnosed With Dementia With Lewy BodiesDementia with Lewy bodiesPh 2Terminated29
Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy BodiesDementia with Lewy bodiesPh 2Completed26